4.8 Article

Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1708447114

Keywords

alternative splicing; BORIS; DNA methylation; cancer; Warburg effect

Funding

  1. Science and Engineering Research Board (SERB) [EMR/2014/000716]
  2. Wellcome Trust/Department of Biotechnology (DBT) India [IA/I/16/2/502719]
  3. Indian Institute of Science Education and Research Bhopal
  4. Council of Scientific and Industrial Research
  5. SERB [PDF/2015/000560]

Ask authors/readers for more resources

Aberrant alternative splicing and epigenetic changes are both associated with various cancers, but epigenetic regulation of alternative splicing in cancer is largely unknown. Here we report that the intragenic DNA methylation-mediated binding of Brother of Regulator of Imprinted Sites (BORIS) at the alternative exon of Pyruvate Kinase (PKM) is associated with cancer-specific splicing that promotes the Warburg effect and breast cancer progression. Interestingly, the inhibition of DNA methylation, BORIS depletion, or CRISPR/Cas9-mediated deletion of the BORIS binding site leads to a splicing switch from cancer-specific PKM2 to normal PKM1 isoform. This results in the reversal of the Warburg effect and the inhibition of breast cancer cell growth, which may serve as a useful approach to inhibit the growth of breast cancer cells. Importantly, our results show that in addition to PKM splicing, BORIS also regulates the alternative splicing of several genes in a DNA methylation-dependent manner. Our findings highlight the role of intragenic DNA methylation and DNA binding protein BORIS in cancer-specific splicing and its role in tumorigenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination

Jiali Yu, Michael D. Green, Shasha Li, Yilun Sun, Sara N. Journey, Jae Eun Choi, Syed Monem Rizvi, Angel Qin, Jessica J. Waninger, Xueting Lang, Zoey Chopra, Issam El Naqa, Jiajia Zhou, Yingjie Bian, Long Jiang, Alangoya Tezel, Jeremy Skvarce, Rohan K. Achar, Merna Sitto, Benjamin S. Rosen, Fengyun Su, Sathiya P. Narayanan, Xuhong Cao, Shuang Wei, Wojciech Szeliga, Linda Vatan, Charles Mayo, Meredith A. Morgan, Caitlin A. Schonewolf, Kyle Cuneo, Ilona Kryczek, Vincent T. Ma, Christopher D. Lao, Theodore S. Lawrence, Nithya Ramnath, Fei Wen, Arul M. Chinnaiyan, Marcin Cieslik, Ajjai Alva, Weiping Zou

Summary: Liver metastases diminish the efficacy of immunotherapy by siphoning activated CD8(+) T cells from systemic circulation, creating systemic immune desert. Combining liver-directed radiotherapy with immunotherapy can promote systemic antitumor immunity.

NATURE MEDICINE (2021)

Article Oncology

Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1

Arpankumar Choksi, Apoorva Parulekar, Richa Pant, Vibhuti Kumar Shah, Ramakrishna Nimma, Priyanka Firmal, Smriti Singh, Gopal C. Kundu, Sanjeev Shukla, Samit Chattopadhyay

Summary: The study demonstrates that SMAR1 inhibits the Warburg effect by promoting PKM1 expression over PKM2 in breast cancer cells. It also shows that SMAR1 deacetylates PTBP1, leading to reduced enrichment of PTBP1 on PKM pre-mRNA and suppression of cancer cell metabolism and tumorigenesis. Additionally, SMAR1 suppresses tumor formation in vivo in a PKM2-dependent manner.

CANCER & METABOLISM (2021)

Review Cell Biology

Interplay within tumor microenvironment orchestrates neoplastic RNA metabolism and transcriptome diversity

Subhashis Natua, Shruti Ganesh Dhamdhere, Srinivas Abhishek Mutnuru, Sanjeev Shukla

Summary: The interaction between heterogeneous cancer cells within a tumor mass and the surrounding microenvironment shapes cancer pathophysiology, affecting immune tolerance, angiogenesis, metastasis, and therapy resistance. This dynamic interaction involves a dramatic reconstruction of the transcriptomic landscape of tumors by altering gene readout synthesis, modifications, stability, and processing.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2022)

Article Multidisciplinary Sciences

BRCA2-DSS1 interaction is dispensable for RAD51 recruitment at replication-induced and meiotic DNA double strand breaks

Arun Prakash Mishra, Suzanne A. Hartford, Sounak Sahu, Kimberly Klarmann, Rajani Kant Chittela, Kajal Biswas, Albert B. Jeon, Betty K. Martin, Sandra Burkett, Eileen Southon, Susan Reid, Mary E. Albaugh, Baktiar Karim, Lino Tessarollo, Jonathan R. Keller, Shyam K. Sharan

Summary: The presence of homologous chromosomes in close proximity to the DNA double strand breaks compensates for the defect in the interaction between tumor suppressor BRCA2 and DSS1, allowing for normal RAD51 recruitment during meiosis.

NATURE COMMUNICATIONS (2022)

Article Medicine, Research & Experimental

Improved loss-of-function CRISPR-Cas9 genome editing in human cells concomitant with inhibition of TGF-β signaling

Tarun Mishra, Vipin Bhardwaj, Neha Ahuja, Pallavi Gadgil, Pavitra Ramdas, Sanjeev Shukla, Ajit Chande

Summary: Strategies to modulate cellular DNA repair pathways have great potential for enhancing the efficiency of CRISPR-Cas9 genome editing. This study describes a reporter-based assay for measuring loss-of-function editing by CRISPR-Cas9 and identifies a small molecule, Repsox, that enhances editing efficiency. Repsox consistently increased CRISPR-Cas9 editing in various cell lines and primary cells, and enabled the generation of HIV-1-resistant cells with high efficiency in human CD4(+) T cells.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Biology

SARS-CoV-2 spike E156G/Δ157-158 mutations contribute to increased infectivity and immune escape

Tarun Mishra, Rishikesh Dalavi, Garima Joshi, Atul Kumar, Pankaj Pandey, Sanjeev Shukla, Ram K. Mishra, Ajit Chande

Summary: Emerging SARS-CoV-2 variants have raised concerns about breakthrough infections. A study sequenced and characterized the spike gene in breakthrough infections associated with the B.1.617 sublineage. The study found that specific spike mutations, such as E156G/Delta 157-158, contributed to increased infectivity and reduced sensitivity to vaccine-induced antibodies.

LIFE SCIENCE ALLIANCE (2022)

Article Genetics & Heredity

Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma

Bing Xia, Kajal Biswas, Tzeh K. Foo, Thiago T. Gomes, Maximilian Riedel-Topper, Eileen Southon, Zhihua Kang, Yanying Huo, Susan Reid, Stacey Stauffer, Weiyin Zhou, Bin Zhu, Hela Koka, Sally Yepes, Seth A. Brodie, Kristine Jones, Aurelie Vogt, Bin Zhu, Brian Carter, Neal D. Freedman, Belynda Hicks, Meredith Yeager, Stephen J. Chanock, Fergus Couch, Dilys M. Parry, Alvaro N. Monteiro, Alisa M. Goldstein, Marcelo A. Carvalho, Shyam K. Sharan, Xiaohong R. Yang

Summary: A study identified rare germline variants in PALB2 and BRCA2 genes that are associated with chordoma susceptibility. These genes play essential roles in homologous recombination and tumor suppression. The study also found a significantly increased burden of rare variants in both genes in chordoma cases compared to population controls. Experimental assays showed that some of these variants affected HR function. These findings contribute to our understanding of chordoma etiology and suggest potential therapeutic options for chordoma patients, such as PARP-1 inhibitors.

HUMAN MUTATION (2022)

Article Medicine, Research & Experimental

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

Shimaa Sherif, Raghvendra Mall, Hossam Almeer, Adviti Naik, Abdulaziz Al Homaid, Remy Thomas, Jessica Roelands, Sathiya Narayanan, Mahmoud Gasim Mohamed, Shahinaz Bedri, Salha Bujassoum Al-Bader, Kulsoom Junejo, Davide Bedognetti, Wouter Hendrickx, Julie Decock

Summary: We identified an immune-related 3-lncRNA signature with prognostic connotation in multiple solid cancer types, which performed equally well and in some cases better than the 20-gene ICR signature, indicating that it could be used as a minimal informative signature for clinical implementation.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Multidisciplinary Sciences

Traceless cysteine-linchpin enables precision engineering of lysine in native proteins

Neelesh C. Reddy, Rajib Molla, Pralhad Namdev Joshi, T. K. Sajeev, Ipsita Basu, Jyotsna Kawadkar, Neetu Kalra, Ram Kumar Mishra, Suman Chakrabarty, Sanjeev Shukla, Vishal Rai

Summary: The authors report a method using cysteine-based chemoselective Linchpin Directed site-selective Modification of lysine residue in a protein, which provides high-level control over reactivity, chemoselectivity, site-selectivity, modularity, dual-probe installation, and protein-selectivity. The method offers protein selectivity by targeting a single lysine residue of a single protein in a complex biomolecular mixture, and it is useful for precision engineering of proteins.

NATURE COMMUNICATIONS (2022)

Article Biochemical Research Methods

Human Behavior-Inspired Linchpin-Directed Catalysis for Traceless Precision Labeling of Lysine in Native Proteins

Kalyani Thakur, T. K. Sajeev, Shivam Kumar Singh, V. Ragendu, Dattatraya Gautam Rawale, Srinivasa Rao Adusumalli, Neetu Kalra, Sanjeev Shukla, Ram Kumar Mishra, Vishal Rai

BIOCONJUGATE CHEMISTRY (2022)

Review Oncology

Genetically engineered mouse models for hereditary cancer syndromes

Kajal Biswas, Altaf Mohammed, Shyam K. Sharan, Robert H. Shoemaker

Summary: Advances in molecular diagnostics have improved the diagnosis and understanding of hereditary cancers. Preclinical experimental models, such as genetically engineered mouse (GEM) models, play a crucial role in studying and preventing cancer in high-risk populations.

CANCER SCIENCE (2023)

Article Multidisciplinary Sciences

Hypoxia-induced loss of SRSF2-dependent DNA methylation promotes CTCF-mediated alternative splicing of VEGFA in breast cancer

Pooja Yadav, Anchala Pandey, Parik Kakani, Srinivas Abhishek Mutnuru, Atul Samaiya, Jharna Mishra

Summary: Alternative splicing of VEGFA generates different isoforms with unique roles in tumor angiogenesis. Our research showed that the splicing factor SRSF2 promotes the formation of anti-angiogenic VEGFA-165b isoform under normal conditions by including exon-8b and inhibiting the expression of pro-angiogenic VEGFA-165a by excluding exon-8a. Under hypoxic conditions, SRSF2 is downregulated by miR-222-3p induced by HIF1 alpha, leading to exon-8b exclusion and reduced VEGFA-165b expression, while increased CTCF recruitment and exon-8a inclusion enhance the expression of VEGFA-165a.

ISCIENCE (2023)

Article Oncology

Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression

Madhura R. Pandkar, Atul Samaiya, Sanjeev Shukla

Summary: This study finds that an enhanced rate of aerobic glycolysis supports the expression of c-Myc through histone lactylation, which further upregulates SRSF10 to drive alternative splicing in breast cancer cells. Restricting the activity of critical glycolytic enzymes affects the c-Myc-SRSF10 axis and reduces the proliferation of breast cancer cells. These findings provide new insights into the molecular mechanisms of breast tumorigenesis and suggest that targeting glycolytic rate may be a potential therapeutic strategy for breast cancer.

TRANSLATIONAL ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

PKM2 dictates the poised chromatin state of PFKFB3 promoter to enhance breast cancer progression

Madhura R. Pandkar, Adarsh Raveendran, Kajal Biswas, Srinivas Abhishek Mutnuru, Jharna Mishra, Atul Samaiya, Tyler Malys, Alexander Y. Mitrophanov, Shyam K. Sharan, Sanjeev Shukla

Summary: The study reveals that non-canonical PKM2 mediates the upregulation of PFKFB3 under hypoxia by facilitating the enrichment of HIF-1α and p300 at PFKFB3 hypoxia-responsive elements. The absence of PKM2 promotes the occupancy of HIF-2α and a poised state of PFKFB3 HREs-associated chromatin, which restricts HIF-2α from inducing PFKFB3 while maintaining its basal-level expression through multiple histone modifications. Shikonin has been demonstrated to inhibit nuclear translocation of PKM2 and effectively suppress PFKFB3 expression, leading to substantial growth inhibition of TNBC patient-derived organoids and MCF7 cells-derived xenograft tumors.

NAR CANCER (2023)

Review Biochemistry & Molecular Biology

ROS production by mitochondria: function or dysfunction?

Flavio R. Palma, Benjamin N. Gantner, Marcelo J. Sakiyama, Cezar Kayzuka, Sanjeev Shukla, Riccardo Lacchini, Brian Cunniff, Marcelo G. Bonini

Summary: In eukaryotic cells, mitochondria are traditionally viewed as the primary organelles responsible for ATP generation under normoxic conditions. However, recent studies have shown that mitochondrial ROS play important signaling functions in cellular adaptation and stress resistance. Contrary to previous beliefs, ROS production is not merely a by-product of dysfunctional mitochondria, but an essential component in cellular adaptation triggered by important stressors.

ONCOGENE (2023)

No Data Available